Ukrainian children's doctors learn new skills from Bristol NHS
Children's clinicians from hospitals in Ukraine are being trained by NHS staff to help them to "prepare for anything" amid the ongoing Russian invasion.Staff from University Hospitals Bristol and Weston NHS Foundation Trust and five other trusts across England are giving their time and expertise throughout the four-week course on paediatric rehabilitation.Participants will then return home to Ukraine to help children suffering from the physical, mental and emotional turmoil of war.Martin Gargan, a consultant at Bristol Royal Hospital for Children, said: "They're hopefully learning something from us and we're learning something from them."
The Ukrainian participants are working with teams in the intensive care, neurorehabilitation and sleep departments to gain new skills and knowledge to take back home.Dr Viktoriya Betsal and Dr Anastasiia Sabadosh work at the children's hospital in Khmelnytskyi. The colleagues said they decided to stay in their home country to "do something useful" throughout the conflict.
Dr Betsal said: "Every city has missiles and attacks from drones, and because of electricity problems, sometimes even to get the healthcare and provide the healthcare for the patient can be difficult. "We need to learn more and find out how to manage it and provide it better."Both doctors said they "really like" the practices in place in Bristol, and they spend many evenings after work discussing how they will implement similar methods in their own teams.
"We have a lot of support here and it's amazing," Dr Sabadosh said. "A lot of doctors try to support us and tell us as much as they can so we can understand and learn here."Dr Batsel added: "Even the small things - how to speak with a patient, how to work with our colleagues - for all these things we thank you."The doctors will return to Ukraine after completing their placements in Bristol at the end of June.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
33 minutes ago
- The Independent
Invasive cancer tests could be dropped for new ‘sponge' method
Thousands of individuals currently monitored for food pipe cancer could be spared invasive diagnostic procedures thanks to a groundbreaking "sponge on a string" test, new research suggests. A study published in The Lancet medical journal indicates that this less invasive method could replace traditional endoscopies for more than half of patients with Barrett's oesophagus, a condition where stomach acid damages the lining of the food pipe, potentially leading to oesophageal cancer. Currently, the NHS offers regular monitoring for Barrett's oesophagus every two to five years, involving an endoscopy where a camera-equipped tube is passed into the oesophagus. This procedure, while effective, is invasive and can be uncomfortable for patients. However, researchers believe a new, less invasive capsule sponge test could offer a viable alternative for many. Already in use in some NHS hospitals for diagnosis, the test involves a patient swallowing a capsule attached to a string. Once swallowed, the capsule dissolves in the stomach, leaving a small sponge. After a few minutes, NHS staff pull the sponge back out via the string, collecting cells from the oesophageal lining for analysis. The new Lancet study, funded by Cancer Research UK, NHS England Cancer Alliance, and Innovate UK, involved 910 participants across 13 UK hospitals. The findings revealed that approximately 15 per cent of patients were identified as being at high risk of developing cancer, while 54 per cent were classified as low risk. The study's authors concluded that the capsule sponge could effectively monitor patients with low-risk Barrett's oesophagus, replacing the need for regular endoscopies. Crucially, the test could be administered by nurses in GP practices, making it more accessible. Professor Peter Sasieni from Cancer Research UK's cancer prevention trials unit at Queen Mary University of London commented: "Our findings suggest that the capsule sponge could help stratify patients with Barrett's oesophagus by risk and that half of them will fall into the low-risk group. 'Given that the risk of these individuals progressing to dysplasia (abnormal cells) and then to oesophageal cancer is so low, it should be safe to replace their usual endoscopy with the capsule sponge." Professor Rebecca Fitzgerald from Cambridge added: "We are very excited by these results, which could lead to a test that is much more accessible and less operator dependent to improve standards for monitoring for patients with Barrett's across the NHS and beyond." Michelle Mitchell, chief executive of Cancer Research UK, also remarked on the breakthrough: "Survival rates for oesophageal cancer have remained unacceptably low for decades, with fewer than 20 per cent of patients surviving for five or more years after diagnosis. Early detection is vital if we are to change this grim statistic." Ms Mitchell hailed the capsule sponge as "one of the most promising breakthroughs in early detection we have seen to date," adding that these new findings bring us closer to transforming diagnosis and treatment. "If adopted widely, this innovative approach could spare significant numbers of people from discomfort and invasive endoscopies. By bringing this more accessible alternative into community care, we have the potential to save more lives."
Daily Mail
37 minutes ago
- Daily Mail
First Briton killed by cyber attack on NHS computers: Hack led to lethal delay in test results
A patient died after a cyber attack caused dangerously long waits for blood test results, an NHS harm review has found. The ransomware attack on pathology firm Synnovis saw more than a thousand operations cancelled as laboratories used by two major hospital trusts were unable to report results. Following the breach last June, a harm review process has been taking place across affected NHS organisations. This includes Guy's and St Thomas', King's College and Lewisham and Greenwich hospitals, in London,; primary care across six London boroughs; and two mental health trusts. This morning, a spokesperson for King's College Hospital Foundation Trust told the Health Service Journal: 'Sadly, one patient sadly died unexpectedly during the cyber-attack. 'As is standard practice when this happens, we undertook a detailed review of their care. 'The patient safety incident investigation identified a number of contributing factors that led to the patient's death. 'This included a long wait for a blood test result as a result of the cyber-attack impacting pathology services at the time. 'We have met with the patient's family, and shared the findings of the safety investigation with them.' The trust said it could not confirm the date of the death or the person's age, citing confidentiality. South East London Integrated Care Board, which is collating the patient harm data, said last week that there were 170 cases linked to the attack, but most of them were classed as 'low harm'. At the time of the incident, GPs described not being able to access test results as like 'flying blind' and pathology networks in south west London and north central London were drafted in to try and cover some of the work Synnovis was unable to do. For three months, GSTT and KCH were unable to do work that involved transfusions or blood matching and were forced to use universal blood types, depleting London stocks to the point where a national appeal had to be launched. The HSJ revealed last year that the attack would have been prevented with the use of simple multi-factor authentication, familiar to most people from online banking and shopping. Synnovis—which is 51 per cent owned by German pathology firm Synlab, with the minority stake controlled by KCH and GSTT—disclosed earlier this year that the total financial impact on the company had been £33m. When asked last month if it had paid the ransom asked of it by the hackers, a spokesperson said: 'Given some sensitivities we are unable to comment at this time.' Last month the Department of Health and Social Care's chief cyber security official Phil Huggins issued an open letter to suppliers working with the NHS urging them to implement multi-factor authentication and some other steps. Synnovis previously said it was working with a taskforce of IT experts to improve standards and policies and conduct rigorous security testing.
The Independent
38 minutes ago
- The Independent
Scientists warn of surprising amount of microplastics found in glass and plastic bottles
Drinks sold in glass bottles, like soda, wine, or beer, may contain more microplastic particles than those in plastic ones, a surprising new study published by France's food safety agency suggests. Microplastics, several times smaller than the width of a single human hair strand, form as plastic waste breaks down into smaller pieces over time, finding their way into the environment and into the bodies of humans and other species. They have been detected almost everywhere, polluting the clouds, the deepest parts of the ocean and on the sides of the world's tallest mountains. A growing body of studies warns that exposure to these particles via the air we breathe and the food we eat could be linked to serious health conditions like strokes, hormone disruptions and several kinds of cancer. Scientists hope to better understand the prevalence of these potentially toxic particles and the ways in which humans get exposed to them. Previous research has found direct evidence linking a key ingredient of plastic bottles to an increased risk of diabetes. Now, a new study published in the Journal of Food Composition and Analysis has found that microplastics are prevalent even in beverages sold in glass bottles. Researchers, including those from the French food safety agency ANSES, found an average of around 100 microplastic particles per litre in glass bottles of soft drinks, lemonade, tea, and beer. This could be five to 50 times greater than the rate found in plastic bottles or metal cans, scientists say. 'Counterintuitively, drinks sold in glass bottles were more contaminated by microplastics,' they wrote in the study. "We expected the opposite result," Iseline Chaib, one of the authors of the new study, told AFP. The study could not directly establish whether there was any health risk from the consumption of such beverages sold in glass bottles or not, due to the lack of toxicological data. Scientists found that the microplastic particles in the glass bottles corresponded to the colour and polymer composition of the paint on their caps, indicating that this was likely the main source of contamination. They recommend that glass bottle manufacturers clean new capsules before capping the bottles to reduce microplastic contamination. 'Pre-cleaning of new capsules, by blowing them out and rinsing them with water/ethanol/water, has significantly reduced the number of MPs (microplastics) per encapsulated bottle, lowering it by approximately three, compared to untreated capsules,' scientists said. Researchers suspect the capsules used for capping glass bottles likely undergo abrasion and surface friction as they collide during storage and transport, causing their particles to flake into bottles. 'Cleaning seems to be essential and could significantly minimise contamination of the liquid in the bottle by paint particles present in the capsule,' they added.
